1.
Vrach Delo
; (4): 81-2, 1989 Apr.
Artigo
em Russo
| MEDLINE
| ID: mdl-2756697
RESUMO
It was established experimentally that antituberculous agents (isoniazide, rifampicin, methazid, ethambutol, PAS) and their combination (isoniazide + rifampicin + PAS; isoniazide + PAS; methazid + PAS) inhibit erythrocytic glucoso-6-phosphate-dehydrogenase, glycerophosphate-dehydrogenase. This should be considered in instituting individual antituberculous therapy.